<DOC>
	<DOCNO>NCT00638079</DOCNO>
	<brief_summary>To evaluate effect food rate extent absorption megestrol acetate 625 mg/5 mL , determine safety tolerability megestrol acetate 625 mg/5 mL healthy individual .</brief_summary>
	<brief_title>Evaluating Effect Food Absorption Megace ES</brief_title>
	<detailed_description />
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Body weight range 60100 kg ( 132220 lb ) body mass index ≥18 ≤32 Healthy History current medical condition could interfere drug consumption , absorption , distribution , metabolism ( eg . CYP450 inducer inhibitor ) , excretion study drug History current medical condition could affect subject safety History frequent nausea emesis , regardless etiology Participation clinical drug study 30 day precede initial dose Significant illness 4 week precede study entry Use medication , include vitamins/herbal/mineral supplement , 7 day precede initial dose Refusal inability abstain food 10 hour proceed 4 hour follow study drug administration , consume FDA high fat meal direct , abstain caffeine xanthinecontaining beverage entirely confinement Any history current drug alcohol abuse Prior alcohol intake exceed equivalent 14 units/week ( 12 oz beer = 4 oz wine = 1.5 oz shot = 1 unit ) average , consumption alcoholic beverage within 48 hour study drug administration History smoke &gt; 25 cigarettes/day within 45 day study drug administration Blood blood product donate within 30 day prior study drug administration , anytime study , except require protocol Positive result urine drug screen , blood alcohol Breathalyzer test , hepatitis B surface antigen , hepatitis B surface antibody ( unless immunize ) , antiHCV</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Food Effect</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Megace ES</keyword>
</DOC>